| Literature DB >> 25584144 |
Jaehwan So1, Junyoung Ahn1, Tae-Hee Lee1, Kyung-Hun Park2, Min-Kyoung Paik2, Mihye Jeong2, Myung-Haing Cho3, Sang-Hee Jeong1.
Abstract
The number of farmers who have suffered from non-fatal acute pesticide poisoning has been reported to vary from 5.7% to 86.7% in South Korea since 1975. Absorption through the skin is the main route of exposure to pesticides for farmers who operate with them. Several in vitro tests using the skins of humans or animal and in vivo tests using laboratory animals are introduced for the assessment of human dermal absorption level of pesticides. The objective of this study is to evaluate and compare international guidelines and strategies of dermal absorption assessments and to propose unique approaches for applications into pesticide registration process in our situation. Until present in our situation, pesticide exposure level to operator is determined just using default value of 10 as for skin absorption ratio because of data shortage. Dermal absorption tests are requested to get exposure level of pesticides and to ultimately know the safety of pesticides for operators through the comparison with the value of AOEL. When the exposure level is higher than AOEL, the pesticide cannot be approved. We reviewed the skin absorption test guidelines recommended by OECD, EFSA and EPA. The EPA recommends assessment of skin absorption of pesticides for humans through the TPA which includes all the results of in vitro human and animal and animal in vivo skin absorption studies. OECD and EFSA, employ a tiered approach, which the requirement of further study depends on the results of the former stage study. OECD guidelines accept the analysis of pesticide level absorbed through skin without radioisotope when the recovery using the non-labeled method is within 80~120%. Various factors are reviewed in this study, including the origin of skin (gender, animal species and sites of skin), thickness, temperature and, etc., which can influence the integrity of results.Entities:
Keywords: AOEL; Dermal absorption; Exposure assessment; Operator safety; Pesticides
Year: 2014 PMID: 25584144 PMCID: PMC4289925 DOI: 10.5487/TR.2014.30.4.251
Source DB: PubMed Journal: Toxicol Res ISSN: 1976-8257
Fig. 1.Procedures for the decision of dermal absorption ratio based on the recommendation by EFSA (2012)9). (A) Upper figure presents a decision tree when there are no data on dermal absorption rate of a pesticide. In that case, starting points are dependent on the solubility of the compound (log Pow) and content of the active substance in a product for the determination of default absorption ratio of a pesticide into the skin of an operator. (B) Bottom figure presents a decision tree when data on dermal absorption rate of a pesticide. In vitro data with human skin, in vitro data with rat and in vivo data with rat are used with tiered approach for the decision of exposure level of a pesticide to an operator.
Fig. 2.Composition of Franz cell. It is an in vitro skin permeation assay apparatus that consists of two primary chambers separated by a membrane. A test material is applied to the membrane via the top chamber and the bottom chamber contains fluid from which samples are taken at regular intervals for analysis. The apparatus is designed to determine the amount of active substance that has permeated the membrane at each time point. Usually, the chamber is maintained at a constant temperature of 37℃.
Comparison of dermal absorption at different anatomical parts of the body of human volunteers
| Anatomical region | Parathion (4 μg/ml in acetone) | Malathion (4 μg/ml in acetone) |
|---|---|---|
|
| ||
| Abdomen | 1.0 | 1.0 |
| Forearm | 0.5 | 0.7 |
| Palm | 0.6 | 0.6 |
| Ball of foot | - | 0.7 |
| Back of hand | 1.1 | 1.3 |
| Inside elbow | 1.5 | - |
| Scalp | 1.7 | - |
| Jaw angle | 1.8 | - |
| Forehead | 2.0 | 2.5 |
| Armpit | 3.5 | 3.1 |
| Scrotum | 5.5 | |
Data are normalized to abdomen = 1.0.
Site- and gender-related differences in the skin thickness and absorption of Benzoic acid
| Type of skin (n) | Skin thickness | % of Applied dose (after 5 hr) | |||
|---|---|---|---|---|---|
|
| |||||
| Stratum corneum | Epidermis (μm) | Whole skin (mm) | |||
|
| |||||
| Male | |||||
| Back (10) | 34.7 ± 2.3 | 61.1 ± 3.0 | 2.80 ± 0.08 | 0.5 ± 0.07 | |
| Abdomen (13) | 12.8 ± 0.08 | 30.4 ± 1.5 | 1.7 ± 0.06 | 5.1 ± 0.9 | |
| Female | |||||
| Back (10) | 18.2 ± 1.0 | 31.2 ± 1.5 | 2.04 ± 0.05 | 2.5 ± 0.6 | |
| Abdomen (13) | 13.7 ± 0.6 | 34.8 ± 1.8 | 0.93 ± 0.02 | 6.5 ± 0.9 | |
Comparison of dermal absorption test guidelines of OECD, EFSA and EPA for exposure assessment
| OECD (Tiered approach) | EFSA (EU) (Tiered approach) | EPA (Triple pack, in vivo tests are mainly performed) | ||
|---|---|---|---|---|
|
| ||||
| Animal | Species | Rat (Other species available) | ||
| Location of skin | Dorsal or ventral | Dorsal, ventral, Femoral | Dorsal or ventral | |
| Human | Preparation of skin | Prefer most human breast, abdomen or leg | ||
| Reconstructed skin | available | not recommended | / | |
| Common | Thickness of skin | 200~400/500 μm | ||
| age | no influence | |||
| Test temperature | 32.1 ± 1℃ | 37℃ | ||
| Tissue storage | −20℃ (Maximum up to 466 days) | |||
| Dose | Finite | |||
| Concentration | Neat formulation and Ready-to-Use dilution | |||
| Volume of test substance | 10 mg or 10 μl/cm2 | 1 mg/cm2 | ||
| Duration of application | 6~8 hrs | Simulate actual environment | ||
| Test duration | Maximum 24 hrs | Maximum 24 hrs | Reasonably adequate duration | |
| Analysis of stratum corneum | Determined according to the situation | Ready for decisionmaking procedures | Determined according to the situation | |
| Recovery | ± 10% (or 20%) | ± 5% | ± 10% (or 20%) | |
| Washing effect | Evaluated in the absorbed amount | No clear decision | ||
Dermal absorption test methods recommendable and available
| Category | Test condition |
|---|---|
|
| |
| Device | Static Franze Cell |
| Skin | Animal : Rat-dorsal skin |
| Human: Cadaver skin or those comes from cosmetic surgery or reconstructed human skin | |
| Non-viable, split thickness (dermatomed) skin (200~400/500 μm) Integrity evaluation: Histological examination, Electrical resistance | |
| Test substance | Dose : Neat formulation and Ready-to-Use dilution, Finite dose |
| Radiolabelled or non-Radiolabelled compound available | |
| The duration of study period | Exposure time: at least 6 to 10 hrs |
| Sampling time: 1 hr, 2 hr, 4 hr, 8 hr and 24 hr after application | |
| Analysis compartment | Applicator, donor chamber dislodgeable from skin surface, |
| Mass balance | Radiolabelled test substance: 90~110% Non-radiolabelled test substance: 80~120% |
| Number of repeat tests | A minimum of 4 repeat tests per one concentration |
Rounded value results of the dermal absorption
| Result range | Example result | Rounded value | |
|---|---|---|---|
|
| |||
| OECD | EFSA | ||
|
| |||
| Above 10% | 10.4% | 10% | 10% |
| 15.6% | 16% | 16% | |
| 1 = 9% | 1.43% | 1% | 1% |
| 2.65% | 3% | 3% | |
| Below 1% | 0.15% | / | 0.2% |